用维生素B治疗耐火性休克12:一个叙述性综述
Courtney Wedemire1, Hamed Samavat2, Melanie Newkirk2
1Department of Dietitian Services, Abbotsford Regional Hospital, Abbotsford, British Columbia, Canada.
概括
高剂量的维生素B12,以氧巴胺的形式服用,有望降低阻断性血管扩张性休克患者的血管压缩剂需求. 然而,证据质量较低,需要进一步研究.
科学领域:
- 关键护理医学 关键护理医学
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 血管扩张性休克,以低血压和低系统性血管抵抗为标志,通常用血管压缩剂治疗.
- 氧化和硫化有助于血管扩张性休克病理生理学.
- 目前正在研究高剂量维生素B12 (Hydroxocobalamin) 对抗这些影响的潜力.
研究的目的:
- 审查目前有关高剂量维生素B12在改善血管扩张性休克成年人血液动力学结果的有效性的文献.
- 为过去五年发表的研究提供最新的分析.
主要方法:
- 在CINAHL,PubMed,Cochrane和EMBASE数据库 (2023年5月) 中进行了全面的文献搜索.
- 纳入标准适用于过去五年内发表的研究.
- 八项研究符合本次审查的资格标准.
主要成果:
- 在包括的八项研究中,有七项报告称,在输入可胺后,血管压缩剂的需求减少.
- 并非所有患者都对氧巴胺治疗有积极反应.
- 研究结果受限于患者选择和结果评估时间的变化.
结论:
- 目前的证据表明,可胺可以改善血管扩张性休克的血液动力学参数,但证据质量较低.
- 氧巴胺用于耐火性血管扩张性休克的使用仍然被认为是研究性的.
- 较大的随机对照试验对于确认维生素B12在治疗血管扩张性休克中的作用至关重要,可能与其他疗法一起进行.
相关概念视频
Blood Pressure Imbalances and Circulatory Shock
784
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
784
Heart Failure Drugs: Inotropic Agents
594
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
594


